Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
48,022
Value
$29.9M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202648,022$29.9M<0.1%+28,970+152.1%AddedHolders
Q1 202619,052$14.7M<0.1%+4,203+28.3%AddedHolders
Q4 202514,849$11.5M<0.1%−16,314−52.4%ReducedHolders
Q3 202531,163$17.5M<0.1%+6,385+25.8%AddedHolders
Q2 202524,778$13.0M<0.1%−18,898−43.3%ReducedHolders
Q1 202543,676$27.7M0.1%+2,027+4.9%AddedHolders
Q4 202441,649$29.7M0.1%−1,093−2.6%ReducedHolders
Q3 202442,742$44.9M0.1%−85,969−66.8%ReducedHolders
Q2 2024128,711$135.3M0.2%−4,471−3.4%ReducedHolders
Q1 2024133,182$128.2M0.2%−5,964−4.3%ReducedHolders
Q4 2023139,146$122.2M0.2%+11,490+9.0%AddedHolders
Q3 2023127,656$105.1M0.2%+3,003+2.4%AddedHolders
Q2 2023124,653$89.6M0.2%+76,094+156.7%AddedHolders
Q1 202348,559$39.9M0.1%−2,298−4.5%ReducedHolders
Q4 202250,857$36.7M0.1%+228+0.5%AddedHolders
Q3 202250,629$34.9M0.1%−9,475−15.8%ReducedHolders
Q2 202260,104$35.5M0.1%+14,405+31.5%AddedHolders
Q1 202245,699$31.9M0.1%−10,524−18.7%ReducedHolders
Q4 202156,223$35.5M0.1%−33,665−37.5%ReducedHolders
Q3 202189,888$54.4M0.1%−8,190−8.4%ReducedHolders
Q2 202198,078$54.8M0.1%−4,258−4.2%ReducedHolders
Q1 2021102,336$48.4M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.